ArkBio Announces Positive Phase II Results of AK3280 for Treatment of Idiopathic Pulmonary Fibrosis

Arkbio China New York

 

Investor Inquiries: [e-mail]  

Logo - https://mma.prnewswire.com/media/2516404/ArkBio_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/arkbio-announces-positive-phase-ii-results-of-ak3280-for-treatment-of-idiopathic-pulmonary-fibrosis-ipf-302456493.html